Does BRIMONIDINE Cause Product packaging quantity issue? 90 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 90 reports of Product packaging quantity issue have been filed in association with BRIMONIDINE (BRIMONIDINE TARTRATE). This represents 0.8% of all adverse event reports for BRIMONIDINE.
90
Reports of Product packaging quantity issue with BRIMONIDINE
0.8%
of all BRIMONIDINE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product packaging quantity issue From BRIMONIDINE?
Of the 90 reports.
Is Product packaging quantity issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BRIMONIDINE. However, 90 reports have been filed with the FAERS database.
What Other Side Effects Does BRIMONIDINE Cause?
Treatment failure (2,849)
Drug ineffective (1,402)
Eye irritation (950)
Ocular hyperaemia (917)
Hypersensitivity (629)
Erythema (604)
Eye pain (560)
Vision blurred (542)
Headache (492)
Dry eye (490)
What Other Drugs Cause Product packaging quantity issue?
LEUPROLIDE (523)
ALBUTEROL (431)
BUDESONIDE\FORMOTEROL (301)
FENTANYL (286)
BUPRENORPHINE (225)
CYCLOSPORINE (206)
ESTRADIOL (201)
BIMATOPROST (177)
RIVAROXABAN (174)
EXENATIDE (154)
Which BRIMONIDINE Alternatives Have Lower Product packaging quantity issue Risk?
BRIMONIDINE vs BRIMONIDINE\BRINZOLAMIDE
BRIMONIDINE vs BRIMONIDINE\TIMOLOL
BRIMONIDINE vs BRINTELLIX
BRIMONIDINE vs BRINZOLAMIDE
BRIMONIDINE vs BRINZOLAMIDE\TIMOLOL